A business in context

VASO research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-090009

  2. 8-K/A · Current report

    Report date 2026-07-31 · 0001213900-26-086128 · Items 9.01

  3. 8-K · Current report

    Report date 2026-07-31 · 0001213900-26-084076 · Items 1.01,2.01,9.01

  4. 8-K · Current report

    Report date 2026-07-23 · 0001213900-26-080991 · Items 5.02,9.01

  5. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-057690

  6. 8-K · Current report

    Report date 2026-05-04 · 0001213900-26-053854 · Items 5.02,9.01

  7. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-037664

  8. 8-K · Current report

    Report date 2026-02-11 · 0001213900-26-015515 · Items 5.03,9.01

  9. 8-K · Current report

    Report date 2025-12-17 · 0001213900-25-123593 · Items 5.07,9.01

  10. 8-K · Current report

    Report date 2025-11-19 · 0001213900-25-112966 · Items 8.01,9.01

  11. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-110955

  12. DEF 14A · Proxy statement

    Report date 2025-12-17 · 0001213900-25-106419

  13. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-076616

  14. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-044213

  15. 10-K · Annual report

    Report date 2024-12-31 · 0001213900-25-026337

  16. 8-K · Current report

    Report date 2025-01-01 · 0001213900-25-000753 · Items 5.02

  17. 4 · Ownership change

    Report date 2024-11-21 · 0001213900-24-101467

  18. 4 · Ownership change

    Report date 2024-11-15 · 0001213900-24-100161

  19. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001213900-24-098378

  20. 8-K · Current report

    Report date 2024-09-17 · 0001213900-24-079992 · Items 1.02,8.01,9.01

  21. 8-K · Current report

    Report date 2024-09-10 · 0001213900-24-077416 · Items 5.07,8.01,9.01

  22. 8-K · Current report

    Report date 2024-08-26 · 0001213900-24-073043 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2024-08-23 · 0001213900-24-072203 · Items 8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001213900-24-068957

  25. DEF 14A · Proxy statement

    Report date 2024-08-26 · 0001213900-24-065802

  26. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001213900-24-043559

  27. 10-K · Annual report

    Report date 2023-12-31 · 0001213900-24-028734

  28. 4/A · Ownership change

    Report date 2023-04-17 · 0001654954-23-015348

  29. 8-K · Current report

    Report date 2023-12-06 · 0001654954-23-015266 · Items 1.01,7.01,9.01

  30. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001654954-23-014359

  31. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001654954-23-010753

  32. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001654954-23-006577

  33. 8-K · Current report

    Report date 2023-04-03 · 0001654954-23-004199 · Items 5.02

  34. 10-K · Annual report

    Report date 2022-12-31 · 0001654954-23-004142

  35. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001654954-22-015274

  36. 4 · Ownership change

    Report date 2019-12-30 · 0001654954-19-014301

  37. 4 · Ownership change

    Report date 2019-06-21 · 0001654954-19-007613

  38. 4 · Ownership change

    Report date 2018-08-16 · 0001654954-18-009402

  39. 4/A · Ownership change

    Report date 2018-03-20 · 0001140361-18-019010

  40. 4 · Ownership change

    Report date 2018-03-20 · 0001140361-18-014635

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000839087VASO Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • VASOMEDICAL, INC · former SEC name · 2012-06-26 to 2016-09-23
  • VASOMEDICAL INC · former SEC name · 1995-10-16 to 2012-05-15

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$86.77M$93.20M
2023-12-31$81.02M$89.59M
2022-12-31$79.29M$91.28M
2021-12-31$75.58M$93.96M
2020-12-31$69.85M$90.94M
2019-12-31$75.52M$99.52M
2018-12-31$73.98M$99.26M
2017-12-31$72.79M$100.05M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗